Citation

Heather Ribaudo, Daniel R. Kuritzkes, Roy (Trip) Gulick. A comparison of three initial antiretroviral AIDS regimens. New England Journal of Medicine. 2007. 357: 1056-7.

Citation

Scott Evans. When and how can endpoints be changed after initiation of a randomized clinical trial?. Public Library of Science Clinical Trials. 2007. 2: e18.

Citation

Brian Wells Pence, Susan Reif, Kathryn Whetten, Jane Leserman, Dalene Stangl, Marvin Swartz, Nathan Thielman, Michael J. Mugavero. Minorities, the poor and survivors of abuse: HIV-infected patients in the US deep south. Journal of the Southern Medical Association. 2007. 100: 1114-22.

Citation

Susan C. Morpeth, John A. Crump, Humphrey J. Shao, Habib O. Ramadhani, Peter R. Kisenge, Cindy A. Moylan, Susanna Naggie, L. Brett Caram, Keren Z. Landman, Noel E. Sam, Dafrosa K. Itemba, John F. Shao, John Alexander Bartlett, Nathan Thielman. Predicting CD4 lymphocyte count <200 cells/mm3 in an HIV type 1-infected African population. AIDS Research and Human Retroviruses. 2007. 23: 1230-6.

Citation

Sharon L. Shriver, Linda L. Millar, Giovanni Schifitto, Dodi Colquhoun, Bradford A. Navia, Robert Lenkinski, Constantin Yiannoutsos, R.Gilberto Gonzalez, Christina M. Marra, Stuart A. Lipton, Linda Chang, Thomas Ernst, Jeffrey G. Jarvik, Eric N. Miller, Elyse J. Singer, Ronald J. Ellis, Dennis Kolson, David M. Simpson, Avindra Nath, Joseph R. Berger. Memantine and HIV-associated cognitive impairment: a neuropsychological and proton magnetic resonance spectroscopy study. AIDS. 2007. 21: 1877-86.

Citation

Richard H. Haubrich, Hongyu Jiang, Ronald Swanstrom, Michael P. Bates, David Katzenstein, Leslie A. Petch, Courtney V. Fletcher, Susan A. Fiscus, Roy (Trip) Gulick. Non-nucleoside phenotypic hypersusceptibility cut-point determination from ACTG 359. HIV Clinical Trials. 2007. 8: 63-7.

Citation

Jack T. Stapleton, Kara Bennett, Ronald J. Bosch, Philip M. Polgreen, Susan Swindells. Effect of antiretroviral therapy and hepatitis C co-infection on changes in lipid levels in HIV-infected patients 48 weeks after initiation of therapy. HIV Clinical Trials. 2007. 8: 429-36.

Citation

Smita A. Kshirsagar, Terrence F. Blaschke, Lewis Sheiner, Mizue Krygowski, Edward P. Acosta, Davide Verotta. Improving data reliability using a non-compliance detection method versus using pharmacokinetic criteria. Journal of Pharmacokinetics & Pharmacodynamics (prev. Journal of Pharmacokinetics and Biopharmaceutics). 2007. 34: 35-55.